Thyroid disease - Whole blood and components

Essential information

Obligatory

Must not donate if:

1. Under investigation.
2. Malignant.
3. Less than 6 months from treatment with radioactive iodine therapy.
4. Less than 24 months from stopping treatment with anti-thyroid tablets.
5. Less than 8 weeks since commencing thyroid replacement therapy (thyroxine).

Discretionary

If on stable maintenance thyroid replacement therapy (thyroxine), and there have been no dose changes in the last 4 weeks, accept.

Supporting information

See if relevant

• Autoimmune disease
• Malignancy
• Surgery

Additional information

An overactive or underactive thyroid increases the risk of heart disease.

Treatments used to treat an overactive thyroid are potentially harmful to the unborn child of a transfused mother.

Reason for change:

The acceptance criteria for donors on long term thyroxine has been reviewed.

Version details:

WB-DSG Edition 203 Release 39 (26 September 2017)